NEW COVERAGE DECISION EXTENDS ABBOTT'S INNOVATIVE PAIN THERAPY OPTION TO 22 MILLION AMERICANS LIVING WITH CHRONIC PAIN

Originally Published by Abbott.

Abbott announced a new national coverage determination for the company’s dorsal root ganglion (DRG) neurostimulation pain therapy through Aetna, a leading health benefits company in the United States. With this coverage decision, Aetna will provide more than 22 million medical plan members with access to Abbott’s DRG therapy for people with chronic pain.


Aetna already covers Abbott’s spinal cord stimulation therapies. Favorable coverage decisions for neurostimulation therapies by private payers such as Aetna support the goals of the U.S. Food and Drug Administration (FDA), Centers for Medicare & Medicaid (CMS) and other government bodies to improve access to non-opioid alternatives for pain management.

Abbott’s DRG therapy is a form of neurostimulation that specifically targets the dorsal root ganglion, a structure along the spinal column which is densely populated with nerves that transmit sensory information to the central nervous system. By blocking or disrupting pain signals transmitted via the DRG, the therapy helps people living with neuropathic pain conditions, some of the most prevalent and under-treated forms of chronic pain in America.

Historically, these conditions have been challenging for physicians to treat because the pain stems from damage to tissue and nerves or results from a disruption in how the peripheral and central nervous systems process or transmit pain signals. Worse, neuropathic pain conditions are often characterized by intense shooting pain or a burning sensation and in their search for pain relief many people try medication, opioids and surgery without success.

Abbott’s Proclaim DRG system has been shown in more than a dozen clinical studies to provide superior pain relief to patients with neuropathic conditions currently underserved by other forms of chronic pain therapy. Examples of these conditions may include chronic pain following hernia repair, total joint replacements or amputation. Patients are also able to try DRG stimulation with a non-invasive weeklong therapy trial, or temporary evaluation, before committing to an implant procedure.

“Since its launch in the U.S., Abbott’s DRG stimulation has had a profound impact for people living with complex pain conditions. One of the most challenging stories we hear is when patients undergo a therapy trial, find pain relief and then learn their insurance won’t cover their therapy,” said Keith Boettiger, vice president of Abbott’s neuromodulation business. “While Medicare already covers our DRG system, it’s encouraging to see private payers like Aetna review the clinical data and outcomes, then choose to provide access to DRG stimulation for their members. These decisions build on the momentum of broader national coverage decisions by private insurers and support the FDA’s goals to find new ways to combat the opioid epidemic with alternatives such as Abbott’s neurostimulation therapies.”

Abbott’s DRG therapy has an extensive history of rigorous scientific research. More than a dozen clinical studies involving more than 500 patients have been published in peer-reviewed journals. The ACCURATE IDE study of Abbott’s DRG therapy was the largest clinical trial to date evaluating patients with complex regional pain syndrome (CRPS) or causalgia. The ACCURATE study, which was used to gain FDA approval, showed that DRG therapy provided significant pain relief to 8 out of 10 people at 12 months. It also showed greater treatment success when compared to patients receiving traditional tonic spinal cord stimulation.

Abbott’s Proclaim DRG system is magnetic resonance (MR) labeled for the head and neck, low maintenance and recharge free, meaning patients do not need to be reminded of their condition and pause from their daily activities to charge their battery as with other systems. Using Bluetooth wireless connectivity, patients can feel empowered by controlling their stimulation levels through a familiar Apple iPod touch device. DRG stimulation therapy is available on the Proclaim DRG Neurostimulation System.

Latest News

Caron Nazario

Virginia Police Pull-Over, Threaten, and Pull Gun on Black Army Lieutenant Because They ‘Missed’ New Purchase Paperwork on Truck He Was Driving

In the latest of a seemingly never-ending stream of cases involving police racism and organizational misbehavior, two police officers in Virginia have been accused of threatening a Black Army lieutenant — and pulling a gun on him — during a routine traffic stop involving vehicle identification. David K. Li of…

Georgia voter suppression protests

More Than 100 Corporate CEOs Discuss Ways to Fight Against Georgia Voter Suppression Law

On Saturday, April 10, the CEOs from dozens of the country’s leading corporations came together on Zoom to talk about ways Corporate America can aid in the fight against a number of controversial and racist voter suppression laws that are currently in discussion across the U.S., including the new law…

moon landing

NASA Plans to Land First Person of Color and First Woman on Moon by 2024

The last manned mission to the moon took place in 1972. Forty-nine years after the Apollo program, NASA is once again talking about lunar space exploration — this time, it will have a focus on diversity and inclusion. Ashley Strickland of CNN has reported that NASA’s newly launched space program,…

student in library

Books Focusing on Race, Diversity, and Inclusion Still Labelled as “Inappropriate” for Students in 2020, American Library Association Reports

American culture as a whole experienced a civil rights reawakening throughout 2020. Although there has been a dramatic increase in calls for social justice, representation and inclusion, this progressive movement still has plenty of detractors, especially in the educational space. According to a new report from the American Library Association,…

Tishaura Jones

Tishaura Jones Becomes Mayor of St. Louis, Joins Growing Number of Black Female Mayors Leading a Major American City

More and more Black women are becoming mayors of large American cities. Tishaura Jones has become the latest in a string of recent women candidates advancing to the top of city leadership. With her win on April 6, Jones becomes the first-ever Black woman mayor of St. Louis. Formerly the…

LinkedIn

Data From 500 Million LinkedIn Accounts Hacked and Put Up for Sale on the Dark Web

In a blow to businesspeople of all levels and industries, the career and business networking site LinkedIn confirmed that data “scraped” from approximately 500 million profiles has been archived by hackers and is being sold on the dark web. The site has approximately 675 million members, meaning that data from…